Seth Klarman · Q3 2014
Baupost Group
Portfolio at the end of Q3 2014, from the 13F filed November 14, 2014. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Micron Technology MU · history | 30.8% | Q2 2013 or earlier | No change |
| Cheniere Energy LNG · history | 15.6% | Q1 2014 | Add 87% |
| Viasat VSAT · history | 11.1% | Q2 2013 or earlier | No change |
| eBay EBAY · history | 6.0% | Q2 2014 | Add 37% |
| Innoviva INVA · history | 5.9% | Q2 2013 or earlier | Reduce 3% |
| Keryx Biopharmaceuticals KERX · history | 4.4% | Q1 2014 | Add 74% |
| Onity Group OCN · history | 3.2% | Q3 2014 | Buy |
| PBF Energy PBF · history | 3.0% | Q3 2013 | Add 28% |
| Antero Resources AR · history | 2.6% | Q3 2014 | Buy |
| Theravance Biopharma TBPH · history | 2.4% | Q2 2014 | No change |
| Veritiv VRTV · history | 2.1% | Q3 2014 | Buy |
| Citigroup C.WS · warrants · history | 2.0% | Q2 2013 or earlier | No change |
| RF Micro Devices RFMD · history | 2.0% | Q1 2014 | No change |
| TriQuint Semiconductor TQNT · history | 2.0% | Q1 2014 | No change |
| SunEdison Semiconductor SEMI · history | 1.4% | Q2 2014 | No change |
| ChipMOS IMOS · history | 1.3% | Q2 2013 or earlier | No change |
| Novagold Resources NG · history | 1.1% | Q2 2013 or earlier | No change |
| Kosmos Energy KOS · history | 0.8% | Q2 2014 | No change |
| Syneron Medical ELOS · history | 0.5% | Q2 2013 or earlier | Reduce 25% |
| Kindred Biosciences KIN · history | 0.5% | Q4 2013 | Add 9% |
| American International Group AIG.WS · warrants · history | 0.3% | Q2 2013 or earlier | No change |
| Innoviva INVA.CV · convertible notes · history | 0.3% | Q3 2014 | Buy |
| Pyxus International AOI · history | 0.2% | Q2 2013 or earlier | No change |
| Boyd Gaming BYD · history | 0.2% | Q2 2014 | Reduce 65% |
| Alon USA Partners ALDW · history | 0.1% | Q4 2013 | No change |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | Add 20% |
| AVEO Oncology AVEO · history | 0.1% | Q2 2013 or earlier | No change |
| 27 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2014, adjusted for stock splits.
Sector weighting
| Technology | 37.4% | |
|---|---|---|
| Energy | 22.2% | |
| Health care | 14.1% | |
| Media & telecom | 11.1% | |
| Consumer discretionary | 6.2% | |
| Financials & real estate | 5.5% | |
| Industrials | 2.1% | |
| Materials | 1.2% | |
| Consumer staples | 0.2% |
What changed from Q2 2014
- Buy Onity Group OCN 3.2% of the 13F
- Buy Antero Resources AR 2.6% of the 13F
- Buy Veritiv VRTV 2.1% of the 13F
- Buy Innoviva INVA.CV 0.3% of the 13F
- Add 87% Cheniere Energy LNG 7.0% → 15.6%
- Add 37% eBay EBAY 3.6% → 6.0%
- Add 74% Keryx Biopharmaceuticals KERX 2.6% → 4.4%
- Add 28% PBF Energy PBF 2.4% → 3.0%
- Add 9% Kindred Biosciences KIN 0.8% → 0.5%
- Add 20% Trilogy Metals TMQ 0.1% → 0.1%
- Reduce 3% Innoviva INVA 9.9% → 5.9%
- Reduce 25% Syneron Medical ELOS 0.7% → 0.5%
- Reduce 65% Boyd Gaming BYD 0.6% → 0.2%
- Sell Idenix Pharmaceuticals IDIX was 20.7%